礼来 (LLY.US)周四宣布，其胰岛素周制剂efsitora在QWINT-1和QWINT-3两项临床3期试验中达到了主要终点，表明这是一种对2型糖尿病成人患者来说更方便的治疗方案。

1,2 The findings of these studies suggest that administration of the long-acting analog insulin glargine increases the risk of cancer in patients with diabetes mellitus, whereas the biguanide ...

MADRID — The de-escalation of a multiple daily injection regimen of insulin for type 2 diabetes to a once-daily fixed-ratio combination of insulin glargine U100 and glucagon-like peptide 1 receptor ...

Lilly and Boehringer Ingelheim have gained EU approval for their biosimilar version of Sanofi's blockbuster insulin product Lantus (insulin glargine). The Europe-wide approval is the first ever ...

Eli Lilly product development senior vice-president Jeff Emmick said: “Once weekly insulins like efsitora have the potential ...

If you've recently received a diagnosis of type 2 diabetes, understanding your treatment options is an important first step.

The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...

The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better ...

Objective — To determine the pharmacokinetic and pharmacodynamic dose-response effects of insulin glargine administered subcutaneously in individuals with type 2 diabetes. Research design and ...

The latest clinical trial results from Eli Lilly show the drug manufacturer's once-weekly insulin injection is just as ...

周四美股成交额第1名英伟达收高0.94%，成交322.14亿美元。美银称，英伟达关键的基本面复苏催化剂可能是未来几周的供应链数据，确认Blackwell新芯片的出货准备就绪。美银的英伟达目标价意味着，预计股价将较本周三涨55%。 此外半导体制造商Xockets周四向美国得州西区地方法院提起诉讼，指控英伟达及其合作伙伴微软侵犯了七项涉及半导体技术的专利，这些技术可将与人工智能计算相关的数据密集型任务 ...